MMP14 and DDR2 are potential molecular markers for metastatic triple-negative breast cancer
Abstract Triple-negative breast cancer (TNBC) is one of the most aggressive and rapidly invasive breast cancer types. TNBC’s potential to metastasize is greater than other types of breast cancer, and current research aims at finding distinct molecular targets that may serve as potential targeted the...
Saved in:
| Main Authors: | Rabeah Al-Temaimi, Rasheed Ahmad, Fahd Al-Mulla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-05538-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging strategies and translational advancements of DDR1 in oncology
by: Yuxi Luo, et al.
Published: (2025-03-01) -
DDR2‐mediated autophagy inhibition contributes to angiotensin II‐induced adventitial remodeling
by: Gaojian Huang, et al.
Published: (2025-06-01) -
Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
by: Herleeyana Meriyani, et al.
Published: (2025-02-01) -
Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement
by: Kaylee Scarnati, et al.
Published: (2025-06-01) -
Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization
by: Qingling He, et al.
Published: (2025-02-01)